Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

Dear Doctor: Not too long ago I developed symptoms of peripheral neuropathy that occurred almost immediately after having an MRI with gadolinium contrast. A physician confirmed that I had retained ...

Camberley nurse Clare Garrett, 45, says she was left needing a wheelchair after she had a private MRI scan in June 2024 ...

Gadolinium retention has not been directly linked to adverse health effects in patients with normal kidney function. The Food and Drug Administration (FDA) announced a new class warning and safety ...

A medical innovation that has significantly advanced medical treatments, magnetic resonance imaging has helped doctors see inside the body. MRI scans are a non-invasive and relatively safe procedure.

BUFFALO, N.Y. — A comprehensive, longitudinal study of patients with multiple sclerosis (MS) that followed patients from the time of their diagnosis for an average of five years, has found that while ...

June 9, 2006 — The U.S. Food and Drug Administration (FDA) has notified healthcare professionals regarding the potential risk for nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy ...

PRINCETON, N.J., March 31, 2017 /PRNewswire/ -- Guerbet LLC., subsidiary of Guerbet Group (FR0000032526 GBT), the global specialist in contrast products and solutions for medical imaging, takes note ...

The U.S. Food and Drug Administration is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as ...